Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Viracta Therapeutics, Inc.
  6. Consensus
    VIRX   US92765F1084

VIRACTA THERAPEUTICS, INC.

(VIRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on VIRACTA THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) VIRACTA THERAPEUTICS, INC.
Analyst Recommendations on VIRACTA THERAPEUTICS, INC.
02/01Viracta Therapeutics Initiated at Outperform by RBC With Speculative Risk Qualifier, Price..
MT
2021VIRACTA THERAPEUTICS : HC Wainwright Starts Viracta Therapeutics at Buy With $35 Price Target
MT
2021VIRACTA THERAPEUTICS : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 Price Target
MT
2021VIRACTA THERAPEUTICS : Evercore ISI Starts Viracta Therapeutics at Outperform with $45 Price Target
MT
More recommendations
Analysis
History shows stocks can weather rate hike cycle
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,07 $
Average target price 20,00 $
Spread / Average Target 866%
High Price Target 36,00 $
Spread / Highest target 1 639%
Low Price Target 8,00 $
Spread / Lowest Target 286%
Consensus detail
Consensus revision (last 18 months)